LncRNA MIR200CHG inhibits EMT in gastric cancer by stabilizing miR-200c from target-directed miRNA degradation

Lina Zhu(Central South University), Xin Wang(Jiangsu University)

Nature Communications

December 8, 2023

10.1038/s41467-023-43974-w

Cited by 67

Related Papers

Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial

|The Lancet Oncology|2021|436

A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome

|Science|2002|370

The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing

|Journal of Translational Medicine|2021|91

miR-302a Inhibits Metastasis and Cetuximab Resistance in Colorectal Cancer by Targeting NFIB and CD44

|Theranostics|2019|86

Potential clinical utility of liquid biopsy in early-stage non-small cell lung cancer

|BMC Medicine|2022|64